Picis announced the immediate availability of an enhancement to its Picis LYNX C/Point[R] revenue management solution designed specifically for hospital-owned chemotherapy clinics. LYNX C/Point mitigates the risk of payer and recovery audit contractor (RAC) penalties by providing consistent and compliant charging and revenue capture support for oncology intravenous (IV) clinic administration services, which are part of an oncology patient's routine treatment. These costly, but undervalued services are under greater scrutiny by the Office of Inspector General because of complex coding rules for infusion and injection procedures. Together with Picis' LYNX E/Point[R] solution, C/Point now provides clinics with the tools to calculate accurate and defensible services for their entire outpatient populations, including chemotherapy infusion centers - meeting …

No comments:
Post a Comment